california utah researchers succeeded preventing one form kidney disease rats potentially opening door prevention kidney failure humans the disease called glomerulonephritis one common causes chronic kidney failure afflicting many 100000 americans year once kidney fails patients must either receive transplant remain dialysis rest lives researchers university utah la jolla cancer research foundation report today british journal nature glomerulonephritis rats caused excess concentrations hormone called transforming growth factorbeta tgfb they found specialized antibodies used remove hormone blood animals thereby prevent onset disease but utah nephrologist wayne border cautioned could many years proposed therapy could used humans for one thing recently discovered tgfb yet linked kidney disease humans although said would incredible werent also playing important role man researchers shown animal experiments therapy halt disease process begun added testtube experiments indicate this important observation opens door treatment humans said dr saulo klahr washington university school medicine president national kidney foundation healthy kidneys act filters remove excess water cellular wastes blood when kidneys fail individual die poisoning within days unless wastes removed artificially dialysis more 130000 americans undergo dialysis routinely maintain health the filtering carried within kidney small units called glomeruli kidney disease occurs glomeruli become clogged abnormally large amounts material called extracellular matrix fibrous meshwork proteins materials this scarring clogging produced diabetes high blood pressure glomerulonephritis immune system attacks glomeruli often aftereffect infection physicians know precise mechanism damage occurs effective therapy exists prevent halt scarring scientists study glomerulonephritis rats injecting protein attacks cells glomeruli damaging inducing formation extracellular matrix studying phenomenon border cellular biologist erkki ruoslahti la jolla foundation discovered formation matrix triggered tgfb released kidney cells damaged the researchers prepared antibodies hormone injected 15 rats time injected protein produces disease the rats also received daily injections antitgfb antibody next six days after seven days researchers examined rats received antitgfb antibody found glomeruli normal border said indicating disease prevented in contrast glomeruli 15 control animals given diseaseproducing protein showed marked scarring inflammation so far evidence tgfb plays similar role glomerulonephritis humans but paper first describe link tgfb kidney disease border said one looked they collecting human blood samples look hormone said also conducting studies determine antitgfb antibodies halt disease process initiated meanwhile ruoslahti colleagues la jolla discovered naturally occurring protein called decorin test tube binds tgfb neutralizes activity much way antibody researchers telios pharmaceuticals la jolla developing techniques produce large quantities decorin order study potential therapeutic use the research may applications well ruoslahti said tgfb may involved diseases excess scarring occurs lung disease may play role process cancer cells tumor metastasize invading parts body developing ability interfere tgfb said might thus therapeutic potential disorders well maugh reported los angeles monroe reported san diego background kidney disease caused diabetes high blood pressure glomerulonephritis affects many 100000 americans year the treatments dialysis kidney transplants the number americans dialysis growing 10 year reaching 130000 1989 costing federal government $ 25 billion year